CYP21A2, as well as MSH5, PPP1R18, and NEU1 have been demonstrated by previous GWASs associated with other autoimmune disorders such as RA, ankylosing spondylitis (AS), T1DM, and SLE (31–33, 43, 44). This evidence concerns the gene PPP1R18 and rheumatoid arthritis.